Literature DB >> 9066363

Increased apolipoprotein E epsilon 4 in epilepsy with senile plaques.

G K Gouras1, N R Relkin, D Sweeney, D G Munoz, I R Mackenzie, S Gandy.   

Abstract

Inheritance of the apolipoprotein E (ApoE) epsilon 4 allele is a risk factor for Alzheimer's disease (AD) and is associated with increased deposition of beta-amyloid (A beta) in AD, Down's syndrome, and normal aging. A beta deposition in the form of senile plaques (SPs) has recently been described in patients with temporal lobe epilepsy (TLE). We studied the relationship between ApoE epsilon 4 genotype and the deposition of A beta in temporal lobe tissue from patients who underwent temporal lobectomy for intractable epilepsy. TLE patients with SPs had a 70% ApoE epsilon 4 carrier frequency compared with a 27% carrier frequency among age-matched TLE controls without SPs. Our data suggest that the association between ApoE epsilon 4 and intracerebral A beta accumulation is not unique to the elderly or to those with dementia, and may be a feature of conditions in which there is both an ApoE epsilon 4 allele and over-production of A beta precursor protein, and, presumably, A beta.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9066363     DOI: 10.1002/ana.410410317

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  27 in total

1.  Neuroinflammatory Cytokines-The Common Thread in Alzheimer's Pathogenesis.

Authors:  W Sue T Griffin; Steven W Barger
Journal:  US Neurol       Date:  2010

2.  The Apolipoprotein E Epsilon (epsilon) 4 Allele Is Important for Trauma-related Epilepsy.

Authors:  Cynthia L. Harden
Journal:  Epilepsy Curr       Date:  2004-01       Impact factor: 7.500

3.  BACE1 elevation is associated with aberrant limbic axonal sprouting in epileptic CD1 mice.

Authors:  Xiao-Xin Yan; Yan Cai; Xue-Mei Zhang; Xue-Gang Luo; Huaibin Cai; Gregory M Rose; Peter R Patrylo
Journal:  Exp Neurol       Date:  2012-01-11       Impact factor: 5.330

4.  ApoE, MemorE, and EpilepsE.

Authors:  Lawrence J Hirsch
Journal:  Epilepsy Curr       Date:  2007 Nov-Dec       Impact factor: 7.500

Review 5.  Growing old with epilepsy: the neglected issue of cognitive and brain health in aging and elder persons with chronic epilepsy.

Authors:  Bruce Hermann; Michael Seidenberg; Mark Sager; Cynthia Carlsson; Barry Gidal; Raj Sheth; Paul Rutecki; Sanjay Asthana
Journal:  Epilepsia       Date:  2007-11-21       Impact factor: 5.864

6.  Endocytosis is required for synaptic activity-dependent release of amyloid-beta in vivo.

Authors:  John R Cirrito; Jae-Eun Kang; Jiyeon Lee; Floy R Stewart; Deborah K Verges; Luz M Silverio; Guojun Bu; Steven Mennerick; David M Holtzman
Journal:  Neuron       Date:  2008-04-10       Impact factor: 17.173

7.  In vivo characterization of the early states of the amyloid-beta network.

Authors:  Jorge Sepulcre; Mert R Sabuncu; Alex Becker; Reisa Sperling; Keith A Johnson
Journal:  Brain       Date:  2013-07       Impact factor: 13.501

8.  Surface fluid registration of conformal representation: application to detect disease burden and genetic influence on hippocampus.

Authors:  Jie Shi; Paul M Thompson; Boris Gutman; Yalin Wang
Journal:  Neuroimage       Date:  2013-04-13       Impact factor: 6.556

9.  Orexin-A is Associated with Increases in Cerebrospinal Fluid Phosphorylated-Tau in Cognitively Normal Elderly Subjects.

Authors:  Ricardo S Osorio; Emma L Ducca; Margaret E Wohlleber; Emily B Tanzi; Tyler Gumb; Akosua Twumasi; Samuel Tweardy; Clifton Lewis; Esther Fischer; Viachaslau Koushyk; Maria Cuartero-Toledo; Mohammed O Sheikh; Elizabeth Pirraglia; Henrik Zetterberg; Kaj Blennow; Shou-En Lu; Lisa Mosconi; Lidia Glodzik; Sonja Schuetz; Andrew W Varga; Indu Ayappa; David M Rapoport; Mony J de Leon
Journal:  Sleep       Date:  2016-06-01       Impact factor: 5.849

Review 10.  Interleukin-1 in the genesis and progression of and risk for development of neuronal degeneration in Alzheimer's disease.

Authors:  W Sue T Griffin; Robert E Mrak
Journal:  J Leukoc Biol       Date:  2002-08       Impact factor: 4.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.